Europe Allergy Treatment Market Growth and Forecast by 2028

Historic Data: 2018-2019 | Base Year: 2020 | Forecast Period: 2021-2028

Europe Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Allergy Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies) and Treatment (Anti-Allergy Drugs and Immunotherapy)

Report Date : May 2021
Report Code : TIPRE00022082

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 155

Page Updated: May 2021

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Europe allergy treatment market is expected to reach US$ 10,424.97 million by 2028 from US$ 6,036.60 million in 2020, it is estimated to grow at a CAGR of 7.1% from 2021 to 2028.

The market growth is attributed to key driving factors such as increase in adoption of immunotherapy in allergy treatment and developments in food allergy treatments. However, the lack of awareness about allergy treatments restrains the market growth.

The allergies are hypersensitive responses from human immune system to the substance that are foreign to the body. While allergies can disturb the normal functioning of organs, severe allergies can be life threatening; for example, asthma leads to poor lung functioning. Although the most effective method of gaining protection against allergies is to avoid being exposed to the known allergens, medications such as steroids and antihistamines are available for treating them. According to a European survey in 2019, in Europe, the prevalence of allergic rhinitis ranges from 17 to 29%, whereas the prevalence of asthma varies from 1.3 to 11% among children and adults. Immunotherapy has shown positive and long-term benefits in allergic patients. In addition, it is suitable for self-administration and medicine usage in homecare settings. Therefore, immunotherapy has emerged as a safe and effective alternative subcutaneous route for both chronic and recurrent allergies. Also, developments in the pharmaceuticals industry have enabled companies to offer treatment for varied allergy reactions. Such developments in the food allergy treatment options and their effectiveness boost the growth of the Europe allergy treatment market.

The rapid growth of COVID-19 cases in Europe has had a major impact on the European economy. Amid COVID-19 outbreak pandemic, it is discovered that a significant number of people across the world are suffering from chronic respiratory diseases such as respiratory allergies, allergic rhinitis, and sinusitis. EAACI, in collaboration with ARIA, in Europe has provided recommendations on operational plans and practical procedures for ensuring optimal standards in the daily clinical care of patients affected by allergic diseases. Therefore, the growing demand for allergy treatments in Europe boosts the growth of the allergy treatment market in the region.

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

EUROPE ALLERGY TREATMENT MARKET SEGMENTATION

By Allergy Type:

Eye Allergy
Rhinitis
Asthma
Skin Allergy
Food Allergies
Other Allergies

By Treatment:

Anti-Allergy Drugs

Antihistamines
Corticosteroids
Decongestants
Other Drugs

Immunotherapy

Sub-cutaneous Immunotherapy (SCIT)
Sub-Lingual Immunotherapy (SLIT)

By Country

UK
Germany
France
Italy
Spain
Rest of Europe

Company Profiles

LETI Pharma
Dermapharm Holding Se
Johnson and Johnson Services, Inc.
Sanofi
AbbVie's Inc.
Pfizer
ALK-Abelló A/S
Allergy Therapeutics
Stallergenes Greer
GlaxoSmithKline PLC

Europe Allergy Treatment Report Scope

Report Attribute	Details
Market size in 2020	US$ 6,036.60 Million
Market Size by 2028	US$ 10,424.97 Million
Global CAGR (2021 - 2028)	7.1%
Historical Data	2018-2019
Forecast period	2021-2028
Segments Covered	By Allergy Type Eye Allergy Rhinitis Asthma Skin Allergy Food Allergies Other Allergies By Treatment Anti-Allergy Drugs and Immunotherapy
Regions and Countries Covered	Europe UK Germany France Russia Italy Rest of Europe
Market leaders and key company profiles	LETI Pharma Dermapharm Holding Se Johnson and Johnson Services, Inc. Sanofi AbbVie's Inc. Pfizer ALK-Abell

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Europe Allergy Treatment Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy